02:40 PM EDT, 08/01/2024 (MT Newswires) -- Eli Lilly ( LLY ) expects its Zepbound weight-loss drug to come out of its shortage in the US in the coming days, Bloomberg quoted CEO David Ricks as saying in an interview on Thursday.

"I think actually today or tomorrow we plan to exit that process," Ricks reportedly said.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 828.66, Change: +24.39, Percent Change: +3.03